Supernus Pharmaceuticals | SUPN - Pendapatan Penjualan





Penjualan Perubahan Tanggal
Abbott USD 11.16B 300M 2026-03
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Canopy Growth CAD 74.54M 7.86M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Eisai JPY 205.43B 14.51B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Novo Nordisk DKK 96.82B 17.68B 2026-03
Pacira USD 177M 19.87M 2026-03
Perrigo USD 969M 141M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03